Supplementary Table S1 from A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy Amr El Zawily , Frederick S. Vizeacoumar , Renuka Dahiya , Sara L. Banerjee , Kalpana K. Bhanumathy , Hussain Elhasasna , Glinton Hanover , Jessica C. Sharpe , Malkon G. Sanchez , Paul Greidanus , R. Greg Stacey , Kyung-Mee Moon , Ilya Alexandrov , Juha P. Himanen , Dimitar B. Nikolov , Humphrey Fonge , Aaron P. White , Leonard J. Foster , Bingcheng Wang , Behzad M. Toosi , Nicolas Bisson , Tajib A. Mirzabekov , Franco J. Vizeacoumar , Andrew Freywald crossref（2023）
摘要
Table S1: Phosphorylated proteins expressed differently in αEPHA2-Cond and cIgG-Tr cells.
更多 查看译文
AI 理解论文
溯源树
样例
